Rasmus Stenlid
Affiliated to Research
E-mail: rasmus.stenlid.2@ki.se
Visiting address: Institutionen för klinisk forskning och utbildning, Södersjukhuset, 11883 Stockholm
Postal address: S1 Klinisk forskning och utbildning, Södersjukhuset, S1 KI SÖS Forskning Kardiologi Svensson, 171 77 Stockholm
About me
MD, PhD
Research
Current translational research interests lie at the intersection of coronary heart disease, obesity, and diabetes, with a particular focus on the role of incretin-based therapies. Broader interests include the metabolic, endocrine, and cardiovascular mechanisms underlying these conditions, and how they can be targeted for improved clinical outcomes.
Articles
- Journal article: CARDIOVASCULAR DIABETOLOGY. 2025;24(1):324
- Journal article: CHILDHOOD OBESITY. 2025
- Journal article: METABOLITES. 2025;15(4):235
- Journal article: PEDIATRIC RESEARCH. 2024;:1-6
- Journal article: DIABETES OBESITY & METABOLISM. 2023;25(12):3757-3765
- Journal article: METABOLITES. 2023;13(8):917
- Journal article: METABOLITES. 2023;13(7):780
- Journal article: FRONTIERS IN ENDOCRINOLOGY. 2023;14:1293093
- Journal article: ANNALS OF NUTRITION AND METABOLISM. 2023;79(6):522-527
- Article: PEDIATRIC OBESITY. 2022;17(8):e12906
- Article: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2022;15(1):182-194
- Journal article: ANNALS OF NUTRITION AND METABOLISM. 2022;78(6):352-358
- Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2018;103(8):2958-2966
- Journal article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2016;101(3):1181-1189
Employments
- Affiliated to Research, Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 2025-2026
Degrees and Education
- PhD, Cardiovascular Risk Factors and Aspects of GLP-1 Treatment in Pediatric Obesity, Medical Cell Biology, Uppsala University, 2025
- Degree Of Master Of Science In Medicine, Karolinska Institutet, 2021